Advertisement

Topics

Latest "Virbac Incorporated" News Stories

00:06 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "Virbac Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Virbac Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Virbac Incorporated for you to read. Along with our medical data and news we also list Virbac Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Virbac Incorporated Companies for you to search.

Showing "Virbac Incorporated" News Articles 1–25 of 94

Wednesday 12th December 2018

Sparton Corporation to Be Acquired by Cerberus

Transaction Provides a Significant Premium to Shareholders and a Strong Partner to Support Future Growth Sparton Corporation (“Sparton” or the “Company”) (NYSE:SPA) today announced that it has entered into a definitive agreement to be acquired by an affiliate of Cerberus Capital Management, L.P. (“Cerberus”), a global leader in alternative ...


Sunday 9th December 2018

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative...

Wednesday 5th December 2018

Virbac : Declaration of the number of shares and voting rights as of November 2018, 30.

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority - Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment BISIN code: FR0000031577 ...


Friday 30th November 2018

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Akebia Shareholders Vote “FOR” Proposed Merger with Keryx

Akebia Urges Shareholders to Vote “FOR” the Merger-Related Shareholder Proposals Today Akebia Therapeutics, Inc. (Nasdaq:AKBA) (“Akebia” or the “Company”) today announced that leading independent proxy advisory firm, Glass Lewis & Co. (“Glass Lewis”), joins Institutional Shareholder Services (“ISS”) in recommending that Akebia s...

Thursday 29th November 2018

Probiodrug AG Reports Third Quarter 2018 Business Update

Probiodrug / Probiodrug AG Reports Third Quarter 2018 Business Update . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Probiodrug AG Reports Third Quarter 2018 Business Update HALLE (SAALE), Germany, 29 November 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company d...

Wednesday 14th November 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is available: ·           on our website: corporate.virbac.com under the section Investors - Financial reports - 2018;·           or on request, under legal and regulatory conditions. ...

Sunday 11th November 2018

BioDuro LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

Summary 2015 - BioDuro is reacquired from PPD. BioDuro and Formex merge to enable service offerings that span from API synthesis to formulation development and cGMP manufacture of drug product. BioDuro LLC BioDuro, a subsidiary of Pharmaceutical Product Development LLC is a discoverer and developer of small molecule and biologics. The institute offers discovery, development and manufacturing...

Thursday 8th November 2018

Ligand Reports Third Quarter 2018 Financial Results

Raises 2018 Financial Guidance Conference Call Begins at 9:00 a.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today b...

Virbac : Declaration of the number of shares and voting rights as of October 2018, 31.

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority - Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment BISIN code: FR0000031577 ...

Wednesday 7th November 2018

Expedeon AG signs supply and license agreement with Quanterix Corporation for access to proprietary immunoassay technology

Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products Heidelberg, Germany and Cambridge, UK, 07 November 2018 – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced a supply and license agreement with United States based Life Sciences company, Quanterix Corporation. The agreement provi...

Tuesday 6th November 2018

Mannatech Reports Third Quarter 2018 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2018. Third Quarter Results Third quarter net

Thursday 1st November 2018

Global Medicinal Feed Additives Market Status and Outlook 20182025 [Report Updated: 14082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Teleflex Reports Third Quarter 2018 Results

Third Quarter Revenues of $609.7 million, up 14.0% Versus Prior Year Period; up 15.0% on Constant Currency Basis Third Quarter GAAP Diluted EPS of $1.21, down 28.8% Over the Prior Year Period Third Quarter Adjusted Diluted EPS of $2.52, up 18.9% Versus Prior Year Period Lowered 2018 Guidance Range for GAAP Revenue Growth f...

Wednesday 17th October 2018

Biocorp partners with Virbac

Tuesday 16th October 2018

Global Pet Dietary Supplements Market Status and Outlook 20182025 [Report Updated: 01082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Arcis Biotechnology and Teleflex sign license agreement

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology Daresbury, UK, 16 October 2018: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis&rs...

Thursday 11th October 2018

Virbac: revenue grew by +5.5% at constant exchange rates at the end of September 2018

Revenue grew by +5.5% at constant exchange rates at the end of September 2018 KEY FIGURES Revenue Year-to-date September 2018 €634.3 million Total growth +0.7% Growth at constant exchange rates +5...

Thursday 4th October 2018

Teleflex Acquires Essential Medical

Acquisition expands presence in structural heart and endovascular aneurysm repair markets by adding unique large bore closure system Teleflex Incorporated (NYSE: TFX) today announced that it has acquired Essential Medical, Inc. Based in Exton, PA, Essential Medical is a privately-held medical device company that has developed and commercialized the CE ...

Wednesday 3rd October 2018

Redx Pharma Plc REDX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

Summary   Redx is a UK biotechnology company and drug development company focused on cancer and fibrosis. Its shares are traded on AIM (AIM:REDX). Redx’s vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.   Redx Pharma Plc REDX Pharmaceuticals Healt...

Saturday 29th September 2018

Global Fire Protection Materials Market Status and Outlook 20182025 [Report Updated: 19082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Friday 21st September 2018

Virbac: Availability_Half-yearly financial report_June 2018_Erratum

Virbac: Availability of the half-yearly financial report as of June 30, 2018 _ Erratum Public release - September 21, 2018 The sales breakdown table on page 3 of the half-year financial report published on September 17, 2018 included distribution errors by geographical area. The corrected table and related comments corrections have been restated in the semi-annual financial report a...

Tuesday 18th September 2018

Virbac SA 2018 Q2 - Results - Earnings Call Slides

Monday 17th September 2018

Virbac: Availability of the half-yearly financial report as of June 30, 2018

Virbac: Availability of the half-yearly financial report as of June 30, 2018 Public release - September 17, 2018 Virbac announced today that the 2018 half-yearly financial report is now available and has been filed with the French financial markets authority (AMF - Autorités des marchés financiers). The half-yearly financial report is available: ·           on our websit...

Virbac : Operating profit up sharply in the first half of 2018

Operating profit up sharply in the first half of 2018 CONSOLIDATED DATA AS OF JUNE 30in € million   2018 2017 2018/2017 Evolution

Tuesday 11th September 2018

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis

Novartis International AG / Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office  The listed ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks